cell transplant (GenVec)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecell transplant (GenVec)
Drug Alias NameHepatoCellhuman liver cells (Diacrin)cell transplant (Diacrin)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEmphysemaHypercholesterolemiaLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDiacrin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenVec IncDiacrin
Active IndicationsN/A
Inactive IndicationsEmphysemaHypercholesterolemiaLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A